Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q96020579
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241221010738.0 |
008
|
|
|
241221nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q96020579
|
024
|
|
|
‡a
0000-0003-2030-598X
‡2
orcid
|
035
|
|
|
‡a
(OCoLC)Q96020579
|
100
|
0 |
|
‡a
Maurilo Leite
‡c
researcher
‡9
en
|
400
|
0 |
|
‡a
Maurilo Leite
‡c
wetenschapper
‡9
nl
|
670
|
|
|
‡a
Author's Brilliant blue G, a P2X7 receptor antagonist, attenuates early phase of renal inflammation, interstitial fibrosis and is associated with renal cell proliferation in ureteral obstruction in rats
|
670
|
|
|
‡a
Author's Development of muffins as dialysis snacks for patients undergoing hemodialysis: results of chemical composition and sensory analysis
|
909
|
|
|
‡a
(orcid) 000000032030598x
‡9
1
|
919
|
|
|
‡a
developmentofmuffinsasdialysissnacksforpatientsundergoinghemodialysisresultsofchemicalcompositionandsensoryanalysis
‡A
Development of muffins as dialysis snacks for patients undergoing hemodialysis: results of chemical composition and sensory analysis
‡9
1
|
919
|
|
|
‡a
brilliantbluegap2x7receptorantagonistattenuatesearlyphaseofrenalinflammationinterstitialfibrosisandisassociatedwithrenalcellproliferationinureteralobstructioninrats
‡A
Brilliant blue G, a P2X7 receptor antagonist, attenuates early phase of renal inflammation, interstitial fibrosis and is associated with renal cell proliferation in ureteral obstruction in rats
‡9
1
|
996
|
|
|
‡2
DNB|1157176240
|
996
|
|
|
‡2
ISNI|0000000068904699
|
996
|
|
|
‡2
PTBNP|66935
|
996
|
|
|
‡2
NSK|000227516
|
996
|
|
|
‡2
PTBNP|181117
|
996
|
|
|
‡2
ISNI|0000000069623282
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|